[HTML][HTML] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

…, C McArthur, BJ McVerry, P Meza-Meneses… - Nature …, 2021 - nature.com
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs)
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …

[HTML][HTML] Epidemiology of systemic mycoses in the COVID-19 pandemic

…, E García-Salazar, P Meza-Meneses… - Journal of Fungi, 2021 - mdpi.com
The physiopathologic characteristics of COVID-19 (high levels of inflammatory cytokines
and T-cell reduction) promote fungal colonization and infection, which can go unnoticed …

[HTML][HTML] Candida glabrata Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination

…, T Ramírez-Lozada, P Meza-Meneses… - Pharmaceutics, 2021 - mdpi.com
In recent years, a progressive increase in the incidence of invasive fungal infections (IFIs)
caused by Candida glabrata has been observed. The objective of this literature review was to …

[HTML][HTML] Hydroxychloroquine for the treatment of severe respiratory infection by COVID-19: a randomized controlled trial

…, NE Rivera-Martinez, P Meza-Meneses… - PLoS …, 2021 - journals.plos.org
Introduction The novel coronavirus pandemic (COVID–19) represents a major public health
problem and it is key to find a treatment that reduces mortality. Our objective was to estimate …

[HTML][HTML] Evaluation of Panbio rapid antigen test for SARS‐CoV‐2 in symptomatic patients and their contacts: a multicenter study

…, DP Cornejo-Juárez, P Meza-Meneses… - International Journal of …, 2021 - Elsevier
Background Point-of-care rapid tests to identify SARS-CoV-2 can have clinical benefits.
Methods A cross-sectional study in adults visiting emergency services or screening sites of …

[HTML][HTML] Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized …

…, C McArthur, BJ McVerry, P Meza-Meneses… - Nature …, 2024 - nature.com
The original version of this article contained an error in Table 1, which misidentified the trial
included in the meta-analysis registered as NCT04323527 as CloroCOVID19II instead of …

Hypoxic hepatitis in cardiac intensive care unit: a study of cardiovascular risk factors, clinical course, and outcomes

…, BV Balderas-Garces, P Meza-Meneses… - … and Clinical Risk …, 2014 - Taylor & Francis
Introduction Hypoxic hepatitis (HH) is observed frequently in intensive care units. Information
in the cardiac intensive care unit (CICU) is limited. The aim of this study was to analyze the …

[HTML][HTML] Effectiveness of Omega-3 Fatty Acid Supplementation in Improving the Metabolic and Inflammatory Profiles of Mexican Adults Hospitalized with COVID-19

…, CR Naranjo-Navarro, PA Meza-Meneses… - Diseases, 2024 - mdpi.com
Background and Objectives: The development of severe COVID-19 is related to the preexistence
of comorbidities and an inadequate nutritional status. The latter is a critical factor for the …

[HTML][HTML] SARS-CoV-2 Vaccine Effectiveness in Hospitalized Patients: A Multicenter Test-Negative Case–Control Study

…, M Pérez-Kawabe, PA Meza-Meneses… - Vaccines, 2023 - mdpi.com
Background: Phase III clinical trials have documented the efficacy of the SARS-CoV-2 vaccines
in preventing symptomatic COVID-19. Nonetheless, it is imperative to continue analyzing …

Infectious complications as a predictor of mortality in patients with non-hodgkin lymphoma receiving rituximab-containing chemotherapy

P Meza-Meneses, P Cornejo-Juárez… - Revista de …, 2019 - medigraphic.com
Background: Rituximab is a monoclonal antibody that increases the disease-free and overall
survival of patients with non-Hodgkin lymphoma (NHL) CD20+. The objective of this study …